RIO DE JANEIRO, BRAZIL - The stress that the coronavirus pandemic has caused in the population in Mexico has led to an increase of up to 30% in the sale of antidepressants compared to the start of the health emergency, Mexican pharmacists said on Wednesday, December 23rd.
“There has been a sustained increase of 30% in the sale of antidepressants since the beginning of the pandemic,” said Juvenal Becerra, president of the National Union of Pharmacy Entrepreneurs (Unefarm), who attributed this situation to “stress caused to the population”.
The increase in the sale of drugs such as diazepam, clonazepam or methylphenidate . . .